Bibliometric analysis of phosphoglycerate kinase 1 expression in breast cancer and its distinct upregulation in triple-negative breast cancer

doi:10.5306/wjco.v15.i7.867

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 7

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1212)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-20) series, Tables (1-8) series.

Item

Count

PDF

HTML

782

Figures (1-20)

106

Tables (1-8)

Sum=1028

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

116

Sum=145

Jul 24, 2024 (publication date) through Nov 12, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical and Translational Research

World J Clin Oncol. Jul 24, 2024; 15(7): 867-894
Published online Jul 24, 2024. doi: 10.5306/wjco.v15.i7.867

Full Size Figure Download Figure

Figure 15 Forest plots of positive likelihood ratio (LRpos) and negative likelihood ratio (LRneg) for phosphoglycerate kinase 1 expression based on different groups. A and B: Breast cancer (BC) vs normal breast tissue; C and D: Triple-negative BC (TNBC) vs normal breast tissue; E and F: TNBC vs non-TNBC tissue.

Citation: Chen JY, Li JD, He RQ, Huang ZG, Chen G, Zou W. Bibliometric analysis of phosphoglycerate kinase 1 expression in breast cancer and its distinct upregulation in triple-negative breast cancer. World J Clin Oncol 2024; 15(7): 867-894
URL: https://www.wjgnet.com/2218-4333/full/v15/i7/867.htm
DOI: https://dx.doi.org/10.5306/wjco.v15.i7.867